4Filing Date: Sep 18, 2026

Hims & Hers Health

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001907056-26-000024
Total Value$354.9K
Trades2
Insiders1

Transaction Details

Okupe Oluyemi
Chief Financial Officer·Direct
Sell · Dispose
Class A Common Stock
Shares-12.31K
Price$28.82
Total Value$354.9K
Shares Owned After251.80K
Transaction DateSep 17, 2026
10b5-1
Footnotes ▸

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Okupe Oluyemi
Chief Financial Officer·Indirect · Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021
Class A Common Stock
Shares0
Price-
Total Value$0
Shares Owned After7.85K
10b5-1Holding Only

Post-Transaction Holdings

Okupe Oluyemi · Chief Financial Officer
SecuritySharesChange
Class A Common Stock259.66K-12.31K (-4.53%)
auto_awesome

Deep Analysis

Hims & Hers CFO Oluyemi Okupe sold 12,313 Class A shares for $354,861 at $28.82 under a Rule 10b5-1 plan adopted May 20, 2026 — a small, pre-scheduled trim, not a discretionary dump.

lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-17 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Hims & Hers Health, Inc. (HIMS) CIK: 0001773751 --- Reporting Owner --- Name: Okupe Oluyemi CIK: 0001907056 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2026-09-17 | Code: S (Open market sale) Shares: -12,313 | Price: $28.82 Total Value: $354,860.66 Shares Owned After: 251,804 | Ownership: D (Direct) Footnotes: [F1] The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. --- Holdings --- [Holding #1] Security: Class A Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. --- Signature --- /s/ /s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe (2026-09-18)

keid analysis is for reference only and does not constitute investment advice.